[Dr.Vad]

In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizations without significant differences in the incidence of ischemic events than regimens that included a vitamin K antagonist, aspirin, or both.
---
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation//AUGUSTUS Investigators//NEJM 2019
[Ссылки доступны только зарегистрированным пользователям ]